Prognostic factors and therapeutic options for relapsed or refractory acute myeloid leukemiaFERRARA, Felicetto; PALMIERI, Salvatore; MELE, Giuseppina et al.Haematologica (Roma). 2004, Vol 89, Num 8, pp 998-1008, issn 0390-6078, 11 p.Article

Arsenic trioxide therapy for relapsed acute promyelocytic leukemia: a bridge to transplantationLEONI, Franco; GIANFALDONI, Giacomo; ANNUNZIATA, Mario et al.Haematologica (Roma). 2002, Vol 87, Num 5, pp 485-489, issn 0390-6078Article

Day 15 bone marrow driven double induction in young adult patients with acute myeloid leukemia: Feasibility, toxicity, and therapeutic resultsFERRARA, Felicetto; IZZO, Tiziana; CRISCUOLO, Clelia et al.American journal of hematology. 2010, Vol 85, Num 9, pp 687-690, issn 0361-8609, 4 p.Article

Acute Promyelocytic Leukemia in Patients Aged Over 60 Years: Multicenter Experience of 34 Consecutive Unselected PatientsFERRARA, Felicetto; FINIZIO, Olimpia; D'ARCO, Alfonso et al.Anticancer research. 2010, Vol 30, Num 3, pp 967-971, issn 0250-7005, 5 p.Article

FLT3 mutations have no prognostic impact in elderly patients with acute myeloid leukemia and normal karyotypeFERRARA, Felicetto; CRISCUOLO, Clelia; RICCARDI, Cira et al.American journal of hematology. 2009, Vol 84, Num 8, pp 532-535, issn 0361-8609, 4 p.Article

Molecular Analysis of PDGFRA and PDGFRB Genes by Rapid Single-strand Conformation Polymorphism (SSCP) in Patients with Core-binding Factor Leukaemias with KIT or FLT3 MutationTROJANI, Alessandra; BARBARA RIPAMONTI, Carla; PEZZETTI, Laura et al.Anticancer research. 2008, Vol 28, Num 5A, pp 2745-2751, issn 0250-7005, 7 p.Article

Rituximab therapy for chronic lymphocytic leukemia-associated autoimmune hemolytic anemiaD'ARENA, Giovanni; LAURENTI, Luca; TARNANI, Michela et al.American journal of hematology. 2006, Vol 81, Num 8, pp 598-602, issn 0361-8609, 5 p.Article

Increased warfarin consumption and residual fibrin turnover in thrombotic patients with primary antiphospholipid syndromeAMES, Paul R. J; MARGAGLIONE, Maurizio; CIAMPA, Antonio et al.Thrombosis research. 2011, Vol 127, Num 6, pp 595-599, issn 0049-3848, 5 p.Article

Fludarabine and cytarabine as continuous sequential infusion for elderly patients with acute myeloid leukemiaFERRARA, Felicetto; D'ARCO, Alfonso M; DE SIMONE, Mariacarla et al.Haematologica (Roma). 2005, Vol 90, Num 6, pp 776-784, issn 0390-6078, 9 p.Article

High-dose idarubicin and busulphan as conditioning to autologous stem cell transplantation in adult patients with acute myeloid leukaemiaFERRARA, Felicetto; PALMIERI, Salvatore; DE SIMONE, Mariacarla et al.British journal of haematology. 2005, Vol 128, Num 2, pp 234-241, issn 0007-1048, 8 p.Article

Efficacy and safety of bendamustine for the treatment of patients with recurring Hodgkin lymphomaCORAZZELLI, Gaetano; ANGRILLI, Francesco; FALORIO, Simona et al.British journal of haematology. 2013, Vol 160, Num 2, pp 207-215, issn 0007-1048, 9 p.Article

Lower dose rituximab is active in adults patients with idiopathic thrombocytopenic purpuraZAJA, Francesco; BATTISTA, Marta Lisa; IPPOLITI, Micaela et al.Haematologica (Roma). 2008, Vol 93, Num 6, pp 930-933, issn 0390-6078, 4 p.Article

Advanced mast cell disease : an Italian Hematological Multicenter experiencePAGANO, Livio; GIOVANNA VALENTINI, Caterina; POGLIANI, Enrico Maria et al.International journal of hematology. 2008, Vol 88, Num 5, pp 483-488, issn 0925-5710, 6 p.Article

Extramedullary involvement at relapse in acute promyelocytic leukemia patients treated or not with all-trans retinoic acid: a report by the Gruppo Italiano Malattie Ematologiche dell'AdultoSPECCHIA, Giorgina; LO COCO, Francesco; LISO, Vincenzo et al.Journal of clinical oncology. 2001, Vol 19, Num 20, pp 4023-4028, issn 0732-183XArticle

Feasibility of peripheral blood stem cell rescue as intensification in elderly patients with acute myelocytic leukaemia : a pilot study from the Gimema GroupMONTILLO, Marco; TEDESCHI, Alessandra; MONACO, Michele et al.British journal of haematology. 2000, Vol 111, Num 1, pp 334-337, issn 0007-1048Article

Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myelomaCAVO, Michele; PANTANI, Lucia; NOZZOLI, Chiara et al.Blood. 2012, Vol 120, Num 1, pp 9-19, issn 0006-4971, 11 p.Article

BeEAM (bendamustine, etoposide, cytarabine, melphalan) before autologous stem cell transplantation is safe and effective for resistant/relapsed lymphoma patientsVISANI, Giuseppe; MALERBA, Lara; FALCIONI, Sadia et al.Blood. 2011, Vol 118, Num 12, pp 3419-3425, issn 0006-4971, 7 p.Article

Dasatinib as first-line treatment for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemiaFOA, Robin; VITALE, Antonella; NOBILE, Francesco et al.Blood. 2011, Vol 118, Num 25, pp 6521-6528, issn 0006-4971, 8 p.Article

M4 acute myeloid leukemia : the role of eosinophilia and cytogenetics in treatment response and survival. The GIMEMA experiencePULSONI, Alessandro; LACOBELLI, Simona; LISO, Vincenzo et al.Haematologica (Roma). 2008, Vol 93, Num 7, pp 1025-1032, issn 0390-6078, 8 p.Article

Imatinib plus steroids induces complete remissions and prolonged survival in elderly philadelphia chromosome-positive patients with acute lymphoblastic leukemia without additional chemotherapy : results of the gruppo italiano malattie ematologiche dell'adulto (GIMEMA) LAL0201-B protocolVIGNETTI, Marco; FAZI, Paola; REGE-CAMBRIN, Giovanna et al.Blood. 2007, Vol 109, Num 9, pp 3676-3678, issn 0006-4971, 3 p.Article

Induction therapy with idarubicin alone significantly influences event-free survival duration in patients with newly diagnosed hypergranular acute promyelocytic leukemia: final results of the GIMEMA randomized study LAP 0389 with 7 years of minimal follow-upAVVISATI, Giuseppe; PETTI, Maria Concetta; GALLO, Eugenio et al.Blood. 2002, Vol 100, Num 9, pp 3141-3146, issn 0006-4971, 6 p.Article

Daunorubicin Versus Mitoxantrone Versus Idarubicin As Induction and Consolidation Chemotherapy for Adults With Acute Myeloid Leukemia: The EORTC and GIMEMA Groups Study AML-10MANDELLI, Franco; VIGNETTI, Marco; THOMAS, Xavier et al.Journal of clinical oncology. 2009, Vol 27, Num 32, pp 5397-5403, issn 0732-183X, 7 p.Article

Efficacy and safety of bortezomib in patients with plasma cell leukemiaMUSTO, Pellegrino; ROSSINI, Fausto; GAY, Francesca et al.Cancer. 2007, Vol 109, Num 11, pp 2285-2290, issn 0008-543X, 6 p.Article

Adult T-cell acute lymphoblastic leukemia : biologic profile at presentation and correlation with response to induction treatment in patients enrolled in the GIMEMA LAL 0496 protocolVITALE, Antonella; GUARINI, Anna; MELONI, Giovanna et al.Blood. 2006, Vol 107, Num 2, pp 473-479, issn 0006-4971, 7 p.Article

The biological characteristics of CD34⁺ CD2⁺ adult acute promyelocytic leukemia and the CD34- CD2-hypergranular (M3) and microgranular (M3v) phenotypesALBANO, Francesco; MESTICE, Anna; LISO, Vincenzo et al.Haematologica (Roma). 2006, Vol 91, Num 3, pp 311-316, issn 0390-6078, 6 p.Article